Literature DB >> 29677490

EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.

Jong-Ho Lee1, Rui Liu2, Jing Li2, Yugang Wang1, Lin Tan3, Xin-Jian Li1, Xu Qian1, Chuanbao Zhang4, Yan Xia1, Daqian Xu1, Wei Guo5, Zhiyong Ding5, Linyong Du1, Yanhua Zheng1, Qianming Chen6, Philip L Lorenzi3, Gordon B Mills5, Tao Jiang4, Zhimin Lu7.   

Abstract

EGFR activates phosphatidylinositide 3-kinase (PI3K), but the mechanism underlying this activation is not completely understood. We demonstrated here that EGFR activation resulted in lysine acetyltransferase 5 (KAT5)-mediated K395 acetylation of the platelet isoform of phosphofructokinase 1 (PFKP) and subsequent translocation of PFKP to the plasma membrane, where the PFKP was phosphorylated at Y64 by EGFR. Phosphorylated PFKP binds to the N-terminal SH2 domain of p85α, which is distinct from binding of Gab1 to the C-terminal SH2 domain of p85α, and recruited p85α to the plasma membrane resulting in PI3K activation. PI3K-dependent AKT activation results in enhanced phosphofructokinase 2 (PFK2) phosphorylation and production of fructose-2,6-bisphosphate, which in turn promotes PFK1 activation. PFKP Y64 phosphorylation-enhanced PI3K/AKT-dependent PFK1 activation and GLUT1 expression promoted the Warburg effect, tumor cell proliferation, and brain tumorigenesis. These findings underscore the instrumental role of PFKP in PI3K activation and enhanced glycolysis through PI3K/AKT-dependent positive-feedback regulation. Published by Elsevier Inc.

Entities:  

Keywords:  EGFR; PFKP; PI3K; phosphorylation; the Warburg effect

Mesh:

Substances:

Year:  2018        PMID: 29677490      PMCID: PMC6114939          DOI: 10.1016/j.molcel.2018.03.018

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  51 in total

1.  AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosis.

Authors:  Haitao Ji; Zhiyong Ding; David Hawke; Dongming Xing; Bing-Hua Jiang; Gordon B Mills; Zhimin Lu
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

2.  Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades.

Authors:  J Deprez; D Vertommen; D R Alessi; L Hue; M H Rider
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

Review 3.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

4.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.

Authors:  C A Koch; D Anderson; M F Moran; C Ellis; T Pawson
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

5.  Crystal structure of human platelet phosphofructokinase-1 locked in an activated conformation.

Authors:  Marco Kloos; Antje Brüser; Jürgen Kirchberger; Torsten Schöneberg; Norbert Sträter
Journal:  Biochem J       Date:  2015-06-11       Impact factor: 3.857

Review 6.  Control of glycolysis through regulation of PFK1: old friends and recent additions.

Authors:  I Mor; E C Cheung; K H Vousden
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-11-17

7.  PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.

Authors:  Weiwei Yang; Yan Xia; David Hawke; Xinjian Li; Ji Liang; Dongming Xing; Kenneth Aldape; Tony Hunter; W K Alfred Yung; Zhimin Lu
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

8.  Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies.

Authors:  S Vora; R Oskam; G E Staal
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

9.  A Grb2-associated docking protein in EGF- and insulin-receptor signalling.

Authors:  M Holgado-Madruga; D R Emlet; D K Moscatello; A K Godwin; A J Wong
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

10.  ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.

Authors:  Weiwei Yang; Yanhua Zheng; Yan Xia; Haitao Ji; Xiaomin Chen; Fang Guo; Costas A Lyssiotis; Kenneth Aldape; Lewis C Cantley; Zhimin Lu
Journal:  Nat Cell Biol       Date:  2012-11-25       Impact factor: 28.824

View more
  38 in total

Review 1.  Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.

Authors:  Yongting Lai; Hairong Huang; Mubalake Abudoureyimu; Xinrong Lin; Chuan Tian; Ting Wang; Xiaoyuan Chu; Rui Wang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 2.  The emerging roles of circular RNAs in regulating the fate of stem cells.

Authors:  Ziyao Zhuang; Lingfei Jia; Weiran Li; Yunfei Zheng
Journal:  Mol Cell Biochem       Date:  2020-09-11       Impact factor: 3.396

Review 3.  Emerging roles of aerobic glycolysis in breast cancer.

Authors:  Z Wu; J Wu; Q Zhao; S Fu; J Jin
Journal:  Clin Transl Oncol       Date:  2019-07-29       Impact factor: 3.405

4.  Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung Carcinoma.

Authors:  Fei Shao; Xueli Bian; Juhong Wang; Daqian Xu; Wei Guo; Hongfei Jiang; Gaoxiang Zhao; Lei Zhu; Shuai Wang; Dongming Xing; Yibo Gao; Jie He; Zhimin Lu
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

5.  Mechanosensitive turnover of phosphoribosyl pyrophosphate synthetases regulates nucleotide metabolism.

Authors:  Jingyi Li; Jichun Shao; Zhijun Zeng; Yumin He; Can Tang; Su Hwan Park; Jong-Ho Lee; Rui Liu
Journal:  Cell Death Differ       Date:  2021-08-31       Impact factor: 15.828

6.  The potential value of cuprotosis (copper-induced cell death) in the therapy of clear cell renal cell carcinoma.

Authors:  Xiaochen Qi; Jin Wang; Xiangyu Che; Quanlin Li; Xiaowei Li; Qifei Wang; Guangzhen Wu
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

7.  Fructose-1,6-bisphosphatase 1 functions as a protein phosphatase to dephosphorylate histone H3 and suppresses PPARα-regulated gene transcription and tumour growth.

Authors:  Zheng Wang; Min Li; Hongfei Jiang; Shudi Luo; Fei Shao; Yan Xia; Mengke Yang; Xiangle Ren; Tong Liu; Meisi Yan; Xu Qian; Haiyan He; Dong Guo; Yuran Duan; Ke Wu; Lei Wang; Guimei Ji; Yuli Shen; Lin Li; Peixiang Zheng; Bofei Dong; Jing Fang; Min Zheng; Tingbo Liang; Haitao Li; Rilei Yu; Daqian Xu; Zhimin Lu
Journal:  Nat Cell Biol       Date:  2022-10-20       Impact factor: 28.213

8.  RNAi-mediated knockdown of PFK1 decreases the invasive capability and metastasis of nasopharyngeal carcinoma cell line, CNE-2.

Authors:  Shuo Li; Peng He; Zhiwei Wang; Meng Liang; Wei Liao; Yili Huang; Mengshi Chi; Fei Liu; Nan Zen; Rongfei Su; Shulin Chen; Zhigang Liu; Haiyu Hong
Journal:  Cell Cycle       Date:  2021-01-06       Impact factor: 4.534

9.  WNT/β-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis.

Authors:  Xueying Yang; Fei Shao; Dong Guo; Wei Wang; Juhong Wang; Rongxuan Zhu; Yibo Gao; Jie He; Zhimin Lu
Journal:  Cell Death Dis       Date:  2021-05-08       Impact factor: 8.469

10.  EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma.

Authors:  Rui Yang; Xiuxiu Li; Yanan Wu; Guanghui Zhang; Xiaoran Liu; Yanping Li; Yonghua Bao; Wancai Yang; Hongjuan Cui
Journal:  Oncogene       Date:  2020-02-07       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.